arrow
K

Kathleen M.M. Vanni

Mass General Brigham
H指数:20
被引数:1,318

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Differences in SARS-CoV-2 antigen persistence in individuals with systemic autoimmune rheumatic diseases compared to the general population: A RECOVER-Adult Cohort Study

系统性自身免疫性风湿病患者与普通人群在SARS-CoV-2抗原持久性方面的差异:一项RECOVER-Adult队列研究

2026-04-270
PRE
Detection of lung abnormalities in smokers with rheumatoid arthritis screened for lung cancer with low-dose chest computed tomography imaging in routine clinical care: Results from a large multi-hospital system

在常规临床护理中,对接受低剂量胸部计算机断层扫描影像检查以筛查肺癌的类风湿关节炎吸烟患者进行肺部异常检测:来自大型多医院系统的研究结果

2025-10-270
PRE
Risk factors for interstitial lung disease in early rheumatoid arthritis and external validation of screening strategies: a cross-sectional analysis of the prospective SAIL-RA cohort in the USA

早期类风湿关节炎间质性肺病的危险因素及筛查策略的外部验证:美国前瞻性SAIL-RA队列的横断面分析

2025-10-140
PRE
Outcomes of Respiratory Syncytial Virus Infection in Patients with Systemic Autoimmune Rheumatic Disease

系统性自身免疫性风湿病患者的呼吸道合胞病毒感染结局

2025-10-040
PRE
Impact of long COVID on self-reported disease activity, disability, and quality of life in individuals with inflammatory arthritis

长新冠对炎性关节炎患者自报疾病活动度、残疾程度和生活质量的影响

2025-04-010
PRE
Patients with systemic autoimmune rheumatic diseases remain at risk for hospitalisation for COVID-19 infection in the Omicron era (2022-2024): a retrospective cohort study

系统性自身免疫性风湿病患者在奥密克戎时代(2022-2024年)仍存在因COVID-19感染住院的风险:一项回顾性队列研究

2025-03-050
OA
Impact of Sex, Serostatus, and Smoking on Risk for Rheumatoid Arthritis-Associated Interstitial Lung Disease Subtypes
2024-10-161
PRE
Factors Associated With an Electronic Health Record-Based Definition of Postacute Sequelae of COVID-19 in Patients With Systemic Autoimmune Rheumatic Disease
2024-03-015
OA
Effectiveness of a fourth dose of COVID-19 mRNA vaccine in patients with systemic autoimmune rheumatic diseases using disease-modifying antirheumatic drugs: an emulated target trial
2024-01-014
OAAI
Breakthrough COVID-19 After Tixagevimab/Cilgavimab Among Patients With Systemic Autoimmune Rheumatic Diseases

系统性自身免疫性风湿性疾病患者中使用Tixagevimab/Cilgavimab后的突破性新型冠状病毒肺炎

2023-10-153
OA
Mortality and immune-related adverse events after immune checkpoint inhibitor initiation for cancer among patients with pre-existing rheumatoid arthritis: a retrospective, comparative, cohort study
2023-05-0112
OAAI
Outcomes with and without outpatient SARS-CoV-2 treatment for patients with COVID-19 and systemic autoimmune rheumatic diseases: a retrospective cohort study
2023-03-0130
OAAI
Risk of severe COVID-19 outcomes associated with rheumatoid arthritis and phenotypic subgroups: a retrospective, comparative, multicentre cohort study
2022-11-0126
OAAI
Assessing the Severity of COVID-19 Lung Injury in Rheumatic Diseases Versus the General Population Using Deep Learning-Derived Chest Radiograph Scores

使用深度学习衍生的胸片评分评估风湿性疾病与普通人群新型冠状病毒肺炎肺损伤的严重程度

2022-10-214
OA
Laboratory trends, hyperinflammation, and clinical outcomes for patients with a systemic rheumatic disease admitted to hospital for COVID-19: a retrospective, comparative cohort study
2021-09-0121
OAAI